In addition to these barriers, emerging evidence suggests that women from certain regions of Africa (e.g., Nigeria) are at greater risk for breast cancer morbidity and mortality due to inherited genetic mutations of BRCA1 and BRCA2 genes that elevate breast cancer risk [16], including risk for triple-negative breast cancer, a highly aggressive form of cancer that rapidly spreads and has limited effective treatment options [17,18,19]. This evidence concerns the gene BRCA2 and breast cancer.